Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Stay Pausing Investments

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Stay Pausing Investments

Global 500, is an annual ranking of the top 500 corporations worldwide

Global 500
Revenue(RF), mln.USD
534
Assets(RF), mln.USD
441
Capital(RF), mln.USD
193
Glob.Revenue, mln.USD
100330
Staff(RF), 2021
1069

In 2008, a legal entity Pfizer LLC was established and the first warehouse of the company's products in Russia was opened. There is no own production in Russia.

The Company Statement
March 14, 2022

Pfizer will donate all profits of the Russian subsidiary to causes that provide direct humanitarian support to the people of Ukraine. There will be no new clinical trials in Russia. Stopped new investments in Russia.

January 31, 2024Axelpharm is suing Wyeth Holdings over a compulsory license for an anticancer drug
February 28, 2023How Pfizer is Responding to the Crisis in Ukraine
January 30, 2023Letter sent by B4Ukraine to the company and the response provided
December 24, 2022Experts reported a decrease in the import of tranquilizers to Russia
June 22, 2022Pfizer's Russian profit pledge bears fruit with $5M initial gift to Ukraine, CEO says
February 02, 2022EFPIA Statement on the crisis in Ukraine
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner